KRAS and neoplasm: The results revealed that there was a significant relationship between the upregulation of the KRAS gene and advanced clinical stages of OC, as well as an increased incidence of both lymphatic and distant metastasis ( p = 0.04, 0.05, 0.02, respectively), suggesting a potential role of KRAS in tumor progression and metastatic behavior.